Skip to main content
. 2016 Jan 4;2016(1):CD006995. doi: 10.1002/14651858.CD006995.pub2

3.18. Analysis.

3.18

Comparison 3 Any antiglucocorticoid versus placebo as adjunct to combination treatment, Outcome 18 Adverse effects: 2a. Specific ‐ extrapyramidal symptoms ‐ average endpoint scores ‐ data only for DHEA (SHRS total, higher score = poor).